Research ArticleEpidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
Keywords: پلیآپ-ریبوز پلی مراز; HCC; hepatocellular carcinoma; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; PARP; polyADP-ribose polymerase; HPRT; hypoxanthine phosphoribosyltransferase; EGFR; HER-3/ErbB-3; Amphiregulin; Gefitinib; ERK;